Intracranial Hemorrhages: Clinical Trials

69 trials for Intracranial Hemorrhages, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 15 unknown, 6 terminated, 5 not yet recruiting. 69 Phase 1, 30 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 169Completed 33, Unknown 15, Terminated 6, Not yet recruiting 5, Recruiting 5, Withdrawn 4, Active not recruiting 1
Phase 230Completed 15, Unknown 8, Not yet recruiting 2, Withdrawn 2, Active not recruiting 1, Recruiting 1, Terminated 1

Follow Intracranial Hemorrhages: new trials by email Literature Review of Intracranial Hemorrhages trials Research Report on Intracranial Hemorrhages

Trials (filtered) newest first · largest first

All 69 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ventricular mTOR Inhibition to Prevent Hydrocephalus After Brain Hemorrhage
Sirolimus (Rapamune®) - Post-hemorrhagic Hydrocephalus (PHH)
Phase 1 / Phase 2Not yet recruitingMassachusetts General Hospital152027-01-012026-06-25
Intra-Arterial Bevacizumab as an Adjunct to Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
Bevacizumab (intra-arterial) - Chronic Subdural Hematoma
Phase 1Not yet recruitingDheeraj Gandhi182027-01-012026-07-27
Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2)
Tirofiban, Placebo - Aneurysmal Subarachnoid Hemorrhage
Phase 1 / Phase 2Not yet recruitingDr David Hasan, M.D.822026-12-052026-11-04
Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)
TNK - Intracerebral Hemorrhage, Intracranial Hemorrhages
Phase 1Not yet recruitingGaurav Gupta, MD52026-09-152026-04-30
An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intravenous Pump-Delivered Propranolol in Patients With ICH
Intravenous Pump-Delivered Propranolol - Intracerebral Hemorrhage, Stroke-Associated Pneumonia (SAP)
Phase 1Not yet recruitingTang-Du Hospital302026-05-012026-04-14
Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events
tocilizumab-aazg (TYENNE) - Aneurysmal Subarachnoid Hemorrhage, Delayed Cerebral Ischemia
Phase 1RecruitingUniversity of Florida302026-03-022026-09-23
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
Psilocybin (Usona Institute) - Stroke, Chronic Stroke
Phase 1RecruitingJohns Hopkins University202026-02-092026-02-13
Stem Cell Therapy for Intracerebral Hemorrhage
Device: Phase Ⅰ Dose Level 1, Device: Phase Ⅰ Dose Level 2, Device: Phase Ⅰ Dose Level 3 - Intracerebral Hemorrhage, Mesenchymal Stem Cell
Phase 1 / Phase 2RecruitingTang Zhouping392025-06-022026-10-20
Minimally Invasive Surgery and rhTNK-tPA for Intracerebral Hemorrhage Evacuation
Minimally invasive surgery plus low-dose rhTNK-tPA group, Minimally invasive surgery plus medium dose rhTNK-tPA group, Minimally invasive surgery plus high dose rhTNK-tPA group - Intracranial Hemorrhages, Cerebrovascular Disorders
Phase 1CompletedBeijing Tiantan Hospital122024-11-042025-03-07
Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection
Bevacizumab 2 mg/kg, Bevacizumab 4 mg/kg - Chronic Subdural Hematoma
Phase 1CompletedThe Cooper Health System102024-06-172026-10-02
Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage
HUFF-01 - Intracerebral Hemorrhage
Phase 1 / Phase 2Active not recruitingHokkaido University Hospital82023-12-012026-10-15
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
Hyperpolarized 13C-Pyruvate - Traumatic Brain Injury, Subarachnoid Hemorrhage
Phase 1RecruitingUniversity of Maryland, Baltimore152023-10-262025-05-11
Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage
Fingolimod - Intracerebral Hemorrhage
Phase 1 / Phase 2UnknownTang-Du Hospital402023-10-112023-10-18
Minocycline Accelerates Intracerebral Hemorrhage Absorption
Minocycline, starch - Intracerebral Hemorrhage
Phase 1UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine902023-01-012022-11-29
Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial
Deferoxamine, placebo - Intracranial Aneurysm, Subarachnoid Hemorrhage
Phase 1 / Phase 2UnknownRadboud University Medical Center402022-12-022023-04-24
Relative Bioavailability of Intravenous GTX-104 Compared to Oral Nimodipine Capsules in Healthy Subjects
GTX-104, Nimodipine Capsules - Aneurysmal Subarachnoid Hemorrhage
Phase 1CompletedGrace Therapeutics Inc.582021-08-262023-08-31
Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?
Long term (continuous) prophylactic antibiotics, 24 hours antibiotics - Subarachnoid Hemorrhage, Intracerebral Hemorrhage
Phase 1RecruitingMontefiore Medical Center842021-06-142026-08-10
Safety and Efficacy Study of Etanercept for Aneurysmal Subarachnoid Hemorrhage
Etanercept - Subarachnoid Hemorrhage, Aneurysmal
Phase 1WithdrawnUnity Health Toronto2021-01-012020-11-02
Efficacy of Percutaneous SPG Block in Aneurysmal SAH
Regional anesthetic SPG block-bilateral - Subarachnoid Hemorrhage, Headache
Phase 1CompletedMayo Clinic22020-11-012024-04-09
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy
HB-adMSCs - Traumatic Brain Injury
Phase 1 / Phase 2CompletedHope Biosciences LLC242020-01-012026-01-15

Showing 20 of 69. Sign in to see all of them.

Narrower conditions

Subarachnoid Hemorrhage (32)  ·  Cerebral Hemorrhage (29)  ·  Stroke (12)  ·  Vasospasm, Intracranial (6)  ·  Aneurysm (5)  ·  Brain Injuries, Traumatic (4)  ·  Hemorrhagic Stroke (4)  ·  Ischemic Stroke (4)  ·  Bronchiolitis Obliterans Syndrome (3)  ·  Hemorrhage (3)  ·  Hydrocephalus (3)  ·  Intracranial Aneurysm (3)  ·  Brain Edema (2)  ·  Central Nervous System Diseases (2)

Broader conditions

Cardiovascular Diseases (69)  ·  Pathologic Processes (69)  ·  Pathological Conditions, Signs and Symptoms (69)  ·  Brain Diseases (68)  ·  Cerebrovascular Disorders (68)  ·  Nervous System Diseases (68)  ·  Vascular Diseases (68)  ·  Central Nervous System Diseases (67)  ·  Hemorrhage (66)  ·  Wounds and Injuries (8)  ·  Signs and Symptoms (7)  ·  Trauma, Nervous System (6)  ·  Craniocerebral Trauma (5)  ·  Hematoma (4)

Interventions

Deferoxamine (3)  ·  Minocycline (3)  ·  Saline Solution (3)  ·  Bevacizumab (2)  ·  Dantrolene (2)  ·  EG-1962 (2)  ·  Mannitol (2)  ·  Nimodipine (2)  ·  Simvastatin (2)  ·  Sodium Chloride (2)  ·  Tirofiban (2)  ·  5-(3-hydroxybenzoyl)-2-thiophenesulfonamide (1)  ·  Acetaminophen (1)  ·  Acupuncture Therapy (1)  ·  Administration, Sublingual (1)

Sponsors

Beijing Tiantan Hospital (2)  ·  Capital Medical University (2)  ·  Edge Therapeutics Inc (2)  ·  Massachusetts General Hospital (2)  ·  Mayo Clinic (2)  ·  Tang-Du Hospital (2)  ·  Thomas Jefferson University (2)  ·  University of Massachusetts, Worcester (2)  ·  Washington University School of Medicine (2)  ·  AegisCN LLC (1)  ·  Augusta University (1)  ·  Baylor College of Medicine (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Brigham and Women's Hospital (1)  ·  CellMed AG, a subsidiary of BTG plc. (1)

Countries

United States (40)  ·  China (9)  ·  Canada (6)  ·  Finland (2)  ·  Germany (2)  ·  Czechia (1)  ·  Israel (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Michael Diringer, MD (2)  ·  Susanne Muehlschlegel, MD (2)  ·  Abba C Zubair (1)  ·  Abbot R. Laptook, MD (1)  ·  Abhik Das, PhD (1)  ·  Adnan I. Qureshi, MD (1)  ·  Ajith J Thomas, MD (1)  ·  Andrew Baker, MD (1)  ·  Barbara J. Stoll, MD (1)  ·  Boguslaw Machalinski, MD, PhD, BSc (1)  ·  Brenda B. Poindexter, MD MS (1)  ·  Brian Hoh, MD (1)  ·  Brian Mac Grory, MD (1)  ·  Brian P Walcott, MD (1)  ·  Brian V Nahed, MD (1)

Results publications

PMID 30739747, PMID 16319269, PMID 18606927, PMID 18658043, PMID 19236490, PMID 19628806, PMID 19770736, PMID 20457956, PMID 21396235, PMID 21454813, PMID 21626077, PMID 22560810, PMID 22989500, PMID 23233387, PMID 24218460, PMID 25072112, PMID 25148012, PMID 25344064, PMID 25549192, PMID 25678453, PMID 26067213, PMID 26409481, PMID 26643677, PMID 26721259, PMID 27932607, PMID 28101148, PMID 28887388, PMID 28928910, PMID 29871521, PMID 30355183, PMID 30428930, PMID 31775069, PMID 31812149, PMID 31900351, PMID 32253717, PMID 32384763, PMID 32391156, PMID 32411082, PMID 32985652, PMID 33236783, PMID 33272131, PMID 33739197, PMID 33841103, PMID 34083595, PMID 34470496, PMID 34873674, PMID 35562205, PMID 35765072, PMID 35769327, PMID 35920945

NIH funding

2015 (1), R01NS044976 (1), R01NS057127 (1), R01NS066929 (1), R44NS071657 (1), U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD027851 (1), U10HD027856 (1), U10HD027871 (1), U10HD027880 (1), U10HD027904 (1), U10HD034216 (1), U10HD036790 (1)